Comparison of non-dihydropyridine calcium channel blockers with beta blockers as treatment for atrial fibrillation: protocol for a systematic review with meta-analysis
Open Access
- 8 January 2026
- journal article
- review article
- Published by Springer Nature in Systematic Reviews
- Vol. 15 (1)
Abstract
Heart rate control is one of the cornerstones of atrial fibrillation (AF) management and is recommended in all AF patients, even as background therapy forKeywords
This publication has 17 references indexed in Scilit:
- Metoprolol vs diltiazem for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis of adverse eventsThe American Journal of Emergency Medicine, 2024
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2024
- What is the Best Agent for Rate Control of Atrial Fibrillation With Rapid Ventricular Response?The Journal of Emergency Medicine, 2022
- Rate control drugs differ in the prevention of progression of atrial fibrillationEP Europace, 2021
- Rate control in atrial fibrillationThe Lancet, 2016
- Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency DepartmentThe Journal of Emergency Medicine, 2015
- Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillationEuropean Heart Journal, 2013
- Comparison of Four Single-Drug Regimens on Ventricular Rate and Arrhythmia-Related Symptoms in Patients With Permanent Atrial FibrillationThe American Journal of Cardiology, 2013
- Lenient versus Strict Rate Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2010
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986